Business Insurance recently published an article on how diabetes can complicate workers’ comp claims and injured worker recovery.
Diabetes can drastically alter the way a person heals and create complications for drug therapy, particularly as GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are making their way into workers’ comp.
The article featured the expertise of many industry leaders, including Silvia Sacalis, BS, PharmD, VP of Clinical Services at Healthesystems.
Read the article in full at Business Insurance to see what Dr. Sacalis has to say about diabetes and its impact on drug therapy in workers’ comp.
Tags: Business Insurance, diabetes, Silvia Sacalis
